Get the Stockscreener App
0.1902
8.69%
0.0152
After Hours:
.21
0.0198
+10.41%
Profusa Inc stock is traded at $0.1902, with a volume of 13.94M.
It is up +8.69% in the last 24 hours and up +0.00% over the past month.
Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
See More
Previous Close:
$0.175
Open:
$0.177
24h Volume:
13.94M
Relative Volume:
1.28
Market Cap:
$12.49M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+18.88%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.1625
$0.194
1-Week Range:
$0.15
$0.194
52-Week Range:
$0.1159
$2.22
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.1902 | 11.49M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.29 | 219.65B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.57 | 146.79B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.95 | 140.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.97 | 130.80B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.98 | 49.16B | 5.88B | 1.34B | 799.60M | 2.3489 |
Profusa Inc Stock (PFSA) Latest News
Q&A: Real-time digital healthcare for 2026 - Digital Journal
Top investors say TSS Inc (TSSI) ticks everything they need - Setenews
Profusa to Present Late Breaking U.S. Based Clinical Trial Update at Paris Vascular Insights 2025 - MarketScreener
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025 - The Manila Times
Profusa (Nasdaq: PFSA) to Share U.S. Lumee PAD Trial Update at PVI 2025 conference - Stock Titan
Profusa (PFSA) Competitors and Alternatives 2025 - MarketBeat
Profusa (PFSA) Stock Forecast and Price Target 2025 - MarketBeat
Profusa, Inc.Common Stock (NQ: PFSA - Markets Financial Content
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Profusa, Inc. (PFSA) -10.7% in Normal Trading: Decline Amid Recent Financial Update - Stocks Telegraph
Profusa raises USD 12M in gross proceeds from convertible PIPE note - Medical Buyer
Profusa Announces Q3 Highlights and Strategic Merger - TipRanks
Profusa, Inc. Announces Third Quarter 2025 Financial Results and Business Highlights - TradingView
Profusa (PFSA) 10K Form and SEC Filings 2025 - MarketBeat
Profusa Announces Third Quarter Business and Financial Highlights - The Manila Times
Profusa, Inc. SEC 10-Q Report - TradingView
[10-Q] Profusa, Inc. Quarterly Earnings Report | PFSA SEC FilingForm 10-Q - Stock Titan
Profusa, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
PFSA News Today | Why did Profusa stock go up today? - MarketBeat
Profusa (PFSA) Stock Price, News & Analysis - MarketBeat
Is Profusa Inc (PFSA) positioned for future growth? - Setenews
Profusa Delays Filing of Quarterly Report - MSN
[NT 10-Q] Profusa, Inc. SEC Filing - Stock Titan
[SCHEDULE 13G/A] Profusa, Inc. SEC Filing - Stock Titan
What is Profusa Inc (PFSA) Stock Return on Shareholders’ Capital? - Setenews
Profusa invests additional $1 million in digital treasury assets - MSN
Profusa, Inc. (PFSA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Profusa Inc (PFSA) looking to reclaim success with recent performance - setenews.com
Profusa, Inc. (PFSA) stock price, news, quote and history - Yahoo! Finance UK
[8-K] Profusa, Inc. Reports Material Event | PFSA SEC FilingForm 8-K - Stock Titan
Profusa outlines EU launch of tissue oxygen monitoring in 2026 - Investing.com India
Profusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026 - MSN
Profusa outlines EU launch of tissue oxygen monitoring in 2026 By Investing.com - Investing.com South Africa
Profusa Unveils Strategic Plan for Revenue Growth - TipRanks
Profusa, Inc. Outlines Path to $250 Million Revenue by 2030 - TradingView
Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches - The Manila Times
Profusa Outlines Potential Path to $250 Million Revenue by - GlobeNewswire
Profusa (PFSA) Stock Skyrockets 36% on Milestone News – Can This Biotech Sensor Play Rebound? - ts2.tech
Why Profusa (PFSA) Stock Soared 36% After Hours? - Benzinga
[424B3] Profusa, Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
Profusa completes manufacturing milestones ahead of 2026 product launch - Investing.com India
Profusa completes manufacturing milestones ahead of 2026 product launch By Investing.com - Investing.com Nigeria
Profusa IncOn track to provide inventory in Q1 2026 - MarketScreener
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026 - GlobeNewswire
Profusa Invests $1 Million in Digital Treasury Assets - MSN
Profusa Unveils Strategic Focus in Investor Update - MSN
Profusa expands European footprint for Lumee Oxygen platform - Investing.com India
Profusa expands European footprint for Lumee Oxygen platform By Investing.com - Investing.com Australia
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe - The Manila Times
Profusa expands sales footprint with new distributor for Lumee Oxygen platform in Europe - MarketScreener
Profusa Inc Stock (PFSA) Financials Data
There is no financial data for Profusa Inc (PFSA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.47%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):